Gabelli Funds LLC Acquires 1,680 Shares of UnitedHealth Group Incorporated $UNH

by · The Markets Daily

Gabelli Funds LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 9.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 19,570 shares of the healthcare conglomerate’s stock after purchasing an additional 1,680 shares during the period. Gabelli Funds LLC’s holdings in UnitedHealth Group were worth $5,295,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Anfield Capital Management LLC boosted its position in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 55 shares during the last quarter. Joseph Group Capital Management bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $27,000. Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group in the fourth quarter valued at about $27,000. Finally, Lifetime Wealth Management P.C. acquired a new stake in UnitedHealth Group in the fourth quarter worth about $29,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.9%

Shares of NYSE UNH opened at $416.89 on Tuesday. The company has a quick ratio of 0.80, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $461.62. The company’s fifty day moving average is $408.53 and its 200-day moving average is $346.11. The stock has a market cap of $378.59 billion, a price-to-earnings ratio of 26.83, a P/E/G ratio of 1.46 and a beta of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter last year, the business posted $4.08 EPS. The firm’s revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 19.69 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a $2.32 dividend. The ex-dividend date was Monday, June 15th. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is presently 59.72%.

Analysts Set New Price Targets

UNH has been the topic of several recent research reports. Morgan Stanley raised their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Truist Financial raised their price objective on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Piper Sandler set a $477.00 price objective on UnitedHealth Group in a research note on Thursday, July 16th. Finally, Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 10th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $455.92.

Check Out Our Latest Research Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Featured Articles